Calbindin (CALB1) (C-Term) Peptide
Quick Overview for Calbindin (CALB1) (C-Term) Peptide (ABIN974397)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- EFNKAFELYD QDGNGYIDEN ELDALLKDLC EKNKQDLDIN NITTYKKNIM
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-CALB1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- CALB1 (Calbindin (CALB1))
-
Background
-
Calbindin is a calcium-binding protein belonging to the troponin C superfamily. It was originally described as a 27-kD protein induced by vitamin D in the duodenum of the chick. In the brain, its synthesis is independent of vitamin-D-derived hormones. Calbindin contains 4 active calcium-binding domains, and 2 modified domains that presumably have lost their calcium-binding capacity. The neurons in brains of patients with Huntington disease are calbindin-depleted.
Alias Symbols: CALB
Protein Interaction Partner: IMPA1,RANBP9,TRPV5,TRPV6,IKBKG,IMPA1,RANBP9
Protein Size: 261 -
Molecular Weight
- 30 kDa
-
Gene ID
- 793
-
NCBI Accession
- NM_004929, NP_004920
-
UniProt
- P05937
Target
-